Medication guide required by FDA for Vivitrol - ONA

Links shared publicly online about this topic.

  • 1,192
    total visits

Medication guide required by FDA for Vivitrol - ONA

oncologynurseadvisor.com

The FDA and Alkermes have notified healthcare professionals and patients of an update to the Warnings, Information for Patients, and Dosage and Administration sections of the Vivitrol (naltrexone injection) Prescribing Information to strengthen language regarding the risk of injection site reactions based on postmarketing reports that had been received prior to June 2009.

View full resource at oncologynurseadvisor.com

Tags: Drug, Healthcare, FDA

  • Share

Most Recently Shared on May 4, 2010 at 9:24 pm By:

ONAcom OncologyNurseAdvisor

Medication guide required by FDA for Vivitrol http://goo.gl/fb/ac7Ad

2 years ago...

Webicina.Com • Blog

webicina.com — “Webicina aims to help physicians enter the web 2.0 era with quality medical information and selected online medical resources.View full resource at webicina.com

  • View Related
  • Share

Most Recently Shared on December 15, 2011 at 6:06 pm By:

Medication Guides Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS)

fda.gov — “Medication Guides Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS)View full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on March 1, 2011 at 6:00 pm By:

FDA warns about increased risk of thigh-bone fracture with bisphosphonates - - Drug Topics

drugtopics.modernmedicine.com — “FDA is requiring a labeling change and Medication Guide to warn patients and healthcare providers about the possible risk of atypical thigh-bone (femoral) fracture in patients who take bisphosphonates for the prevention and treatment of osteoporosis.View full resource at drugtopics.modernmedicine.com

  • View Related
  • Share

Most Recently Shared on November 16, 2010 at 5:07 am By:

Drugs_Devices Drugs and Devices OW OW Health

FDA warns about increased risk of thigh-bone fracture with bisphosphonates: FDA is requiring a labeling ... http://bit.ly/cTktSi #pharma

1 year ago...

FDA warns about increased risk of thigh-bone fracture with bisphosphonates - - Drug Topics

drugtopics.modernmedicine.com — “FDA is requiring a labeling change and Medication Guide to warn patients and healthcare providers about the possible risk of atypical thigh-bone (femoral) fracture in patients who take bisphosphonates for the prevention and treatment of osteoporosis.View full resource at drugtopics.modernmedicine.com

  • View Related
  • Share

Most Recently Shared on October 19, 2010 at 4:46 am By:

Drugs_Devices Drugs and Devices OW OW Health

FDA warns about increased risk of thigh-bone fracture with bisphosphonates: FDA is requiring a labeling chang... http://bit.ly/bFIwJx #drug

1 year ago...

FDA Alert: Vivitrol (naltrexone for extended-release injectable suspension): Medication Guide Required for Patients

drugs.com — “FDA Alert: Vivitrol (naltrexone for extended-release injectable suspension): Medication Guide Required for PatientsView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on May 4, 2010 at 11:50 pm By:

drugscom Drugs.com Health Site

FDA Alert - Vivitrol: Medication Guide Required for Patients - http://bit.ly/cWVMId

2 years ago...

Medication guide required by FDA for Vivitrol - MPR

empr.com — “The FDA and Alkermes have notified healthcare professionals and patients of an update to the Warnings, Information for Patients, and Dosage and Administration sections of the Vivitrol (naltrexone injection) Prescribing Information to strengthen language regarding the risk of injection site reactions based on postmarketing reports that had been received prior to June 2009.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on May 4, 2010 at 9:52 pm By:

eMPR MPR Medical Publisher

MPR News: Medication guide required by FDA for Vivitrol: The FDA and Alkermes have notified healthcare professiona... http://bit.ly/c5ZO44

2 years ago...

FDA calls for labeling changes, medication guides for two topical testosterone gels

endocrinetoday.com — “The U.S. Food and Drug Administration today announced that it is requiring manufacturers of two prescription topical testosterone gel products,View full resource at endocrinetoday.com

  • View Related
  • Share

Most Recently Shared on May 11, 2009 at 2:15 pm By:

EndocrineToday Endocrine Today Health News

FDA calls for labeling changes, medication guides for two topical testosterone gels: http://tinyurl.com/test-gel

3 years ago...

Advertisement